These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 21474829

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH.
    Baron M, Leroyer AS, Majd Z, Lalloyer F, Vallez E, Bantubungi K, Chinetti-Gbaguidi G, Delerive P, Boulanger CM, Staels B, Tailleux A.
    Atherosclerosis; 2011 Sep; 218(1):69-76. PubMed ID: 21529810
    [Abstract] [Full Text] [Related]

  • 3. Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates.
    Shiri-Sverdlov R, Wouters K, van Gorp PJ, Gijbels MJ, Noel B, Buffat L, Staels B, Maeda N, van Bilsen M, Hofker MH.
    J Hepatol; 2006 Apr; 44(4):732-41. PubMed ID: 16466828
    [Abstract] [Full Text] [Related]

  • 4. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect.
    Yan F, Wang Q, Xu C, Cao M, Zhou X, Wang T, Yu C, Jing F, Chen W, Gao L, Zhao J.
    PLoS One; 2014 Apr; 9(6):e99245. PubMed ID: 24926685
    [Abstract] [Full Text] [Related]

  • 5. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC.
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.
    Montagner A, Polizzi A, Fouché E, Ducheix S, Lippi Y, Lasserre F, Barquissau V, Régnier M, Lukowicz C, Benhamed F, Iroz A, Bertrand-Michel J, Al Saati T, Cano P, Mselli-Lakhal L, Mithieux G, Rajas F, Lagarrigue S, Pineau T, Loiseau N, Postic C, Langin D, Wahli W, Guillou H.
    Gut; 2016 Jul; 65(7):1202-14. PubMed ID: 26838599
    [Abstract] [Full Text] [Related]

  • 8. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms.
    Mezei O, Li Y, Mullen E, Ross-Viola JS, Shay NF.
    Physiol Genomics; 2006 Jun 16; 26(1):8-14. PubMed ID: 16507786
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R, Yu Y, Hu S, Zhang J, Yang H, Han B, Cheng Y, Luo X.
    Nutr Res; 2016 Sep 16; 36(9):1022-1030. PubMed ID: 27632923
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Atheroprotective effect of human apolipoprotein A5 in a mouse model of mixed dyslipidemia.
    Mansouri RM, Baugé E, Gervois P, Fruchart-Najib J, Fiévet C, Staels B, Fruchart JC.
    Circ Res; 2008 Aug 29; 103(5):450-3. PubMed ID: 18658049
    [Abstract] [Full Text] [Related]

  • 16. Effect of beta-3 adrenoceptor stimulation on the levels of ApoA-I, PPARα, and PPARγ in apolipoprotein E-deficient mice.
    Shi ST, Li YF, Guo YQ, Wang ZH.
    J Cardiovasc Pharmacol; 2014 Nov 29; 64(5):407-11. PubMed ID: 24979391
    [Abstract] [Full Text] [Related]

  • 17. Eicosapentaenoic acid improves hepatic steatosis independent of PPARα activation through inhibition of SREBP-1 maturation in mice.
    Tanaka N, Zhang X, Sugiyama E, Kono H, Horiuchi A, Nakajima T, Kanbe H, Tanaka E, Gonzalez FJ, Aoyama T.
    Biochem Pharmacol; 2010 Nov 15; 80(10):1601-12. PubMed ID: 20691165
    [Abstract] [Full Text] [Related]

  • 18. Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity.
    Stec DE, Gordon DM, Hipp JA, Hong S, Mitchell ZL, Franco NR, Robison JW, Anderson CD, Stec DF, Hinds TD.
    Am J Physiol Regul Integr Comp Physiol; 2019 Nov 01; 317(5):R733-R745. PubMed ID: 31483154
    [Abstract] [Full Text] [Related]

  • 19. Fish oil and fenofibrate prevented phosphorylation-dependent hepatic sortilin 1 degradation in Western diet-fed mice.
    Li J, Bi L, Hulke M, Li T.
    J Biol Chem; 2014 Aug 08; 289(32):22437-49. PubMed ID: 24986865
    [Abstract] [Full Text] [Related]

  • 20. PPARalpha, but not PPARgamma, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemia.
    Hennuyer N, Tailleux A, Torpier G, Mezdour H, Fruchart JC, Staels B, Fiévet C.
    Arterioscler Thromb Vasc Biol; 2005 Sep 08; 25(9):1897-902. PubMed ID: 15994444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.